These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8415248)

  • 1. [Trimetazidine therapy in atrio-cochlear disturbances of vascular origin].
    Kozakiewicz K; Wróbel M; Petelenz T; Lepkowski A; Skrzypek-Wańha J; Chruściel TL
    Pol Tyg Lek; 1993 Apr 5-12; 48(14-15):327-9. PubMed ID: 8415248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The efficacy of trimetazidine in cochleovestibular disorders of ischemic origin. A crossover control versus placebo trial].
    Coyas A
    Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():82-7. PubMed ID: 2241007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamics of cochleovestibular disorders in patients with early manifestations of cerebral circulation insufficiency].
    Kuklina EV
    Vestn Otorinolaringol; 1989; (4):13-6. PubMed ID: 2800118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ischemic cochlear vestibular syndromes].
    Putilina MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6):35-9. PubMed ID: 22983237
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic policy in cochleovestibular disorders in the presence of cerebral circulatory insufficiency].
    Kunel'skaia NL; Kamchatnov PR; Gulieva AE
    Vestn Otorinolaringol; 2008; (1):47-50. PubMed ID: 18454057
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cavinton in the treatment of cochleovestibular disorders of vascular genesis].
    Kunel'skaia NL; Gulieva AE; Ianiushkina ES; Chugunova MI
    Vestn Otorinolaringol; 2009; (5):52-4. PubMed ID: 20041504
    [No Abstract]   [Full Text] [Related]  

  • 7. [Betaserk efficiency in cochlear and vestibular disorders in the regional surdocenter].
    Pekaskiĭ SI
    Vestn Otorinolaringol; 2001; (3):61. PubMed ID: 11510053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of monotreane in the treatment of patients with cochleovestibular disorders].
    Pal'chun VT; Kadymova MI; Kriukov AI
    Vestn Otorinolaringol; 1989; (5):20-2. PubMed ID: 2588407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Angiogenic cochleo-vestibular diseases and dyslipoproteinemia: new insight].
    Petukhova NA
    Vestn Otorinolaringol; 2002; (2):52-4. PubMed ID: 12056167
    [No Abstract]   [Full Text] [Related]  

  • 10. [The estimation of the efficacy of manual therapy included in the combined treatment of cochlear-vestibular disorders based on the results of computed stabilography].
    Shempeleva AÉ; Lopatin AS; Morozova SV; Gridin LA
    Vestn Otorinolaringol; 2012; (2):45-8. PubMed ID: 22810637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of effectiveness of treatment of cochleovestibular disorders with mildronate].
    Luchikhin LA; Pankova TB; Kakymov MI
    Vestn Otorinolaringol; 1991; (2):36-40. PubMed ID: 2048251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of betaserk in patients with cochlear-vestibular disorders].
    Kadymov MI; Poliakova TS; Vladimirova TN
    Vestn Otorinolaringol; 1998; (5):49-50. PubMed ID: 9793432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vestibo in the treatment of cochleovestibular disorders].
    Kunel'skaia NL; Levina IuV; Doronina OM; Krasiuk AA; Izotova GN
    Vestn Otorinolaringol; 2008; (6):52-4. PubMed ID: 19209416
    [No Abstract]   [Full Text] [Related]  

  • 14. [Betaserk in therapy of cochleovestibular disordes].
    Khrapko NS; Sedykh MI; As'kova LN; Tarasova NV; Velikanov AK; Baryshevskaia LA
    Vestn Otorinolaringol; 2006; (4):59-60. PubMed ID: 17152479
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacological correction of cochleovestibular impairments].
    Pal'chun VT; Poliakova TS; Kunel'skaia NA; Bogdanets SA
    Vestn Otorinolaringol; 2004; (4):36-9. PubMed ID: 15496841
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rational selection of vasoactive drugs for the treatment of patients with vestibular dysfunction].
    Boĭko NV
    Vestn Otorinolaringol; 1991; (5):42-7. PubMed ID: 1755185
    [No Abstract]   [Full Text] [Related]  

  • 17. Cochleovestibular dysfunction caused by cerebrovascular diseases.
    Szirmai A
    Int Tinnitus J; 2005; 11(1):63-5. PubMed ID: 16419693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effectiveness of stabilographic vertebrogenic test in diagnosing secondary cochleovestibular disorders].
    Luchikhin LA
    Vestn Otorinolaringol; 1992; (5-6):56-9. PubMed ID: 1307668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correction of autonomic sensory disorders in middle ear diseases].
    Morozova SV; Zaĭtseva OV
    Vestn Otorinolaringol; 2002; (3):38-41. PubMed ID: 12227028
    [No Abstract]   [Full Text] [Related]  

  • 20. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
    Belardinelli R; Lacalaprice F; Faccenda E; Volpe L
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):533-40. PubMed ID: 18797405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.